The second Jamaica Health and Lifestyle Survey completed in 2007−2008 provided 
INTRODUCTION
The most current Jamaica Health and Lifestyle Survey, conducted between 2007 and 2008, is the second of such surveys conducted in Jamaica and will now form the basis of strategic initiative aimed at reducing health burden and improving quality of life (1) .
In the previous study of 2000−2001, the prevalence of hypertension was 20.9% (95% confidence interval (CI) 18. 4 The acceptance that compliance with medication regimen is well established as improving hypertensive care (4) is certainly one motivation to continue the current free access to antihypertensive drugs for persons living with this disease (1). However, it will serve the health sector well to remember patients' resistance to a lifetime commitment to drugs, daily routines and their abhorrence of seemingly inescapable adverse effects will forever be a significant barrier to compliance.
SUBJECTS AND METHODS
During the period June-July 2012, a questionnaire-based survey approved by the University Hospital of the West Indies/University of the West Indies/Faculty of Medical Sciences Ethics Committee was conducted among hypertensive persons presenting to the ambulatory section of the Emergency Medicine Division of the University Hospital of the West Indies for reasons related or unrelated to hypertension. Fifty-two persons who indicated that they were prescribed medication for hypertension consented to completing the questionnaire aimed at evaluating reasons for non-compliance. Of the group, 33 (63.5%) indicated that they were taking their prescribed antihypertensive medication. Blood pressures were measured at the time of completing the questionnaire. Of the 19 hypertensive participants not taking their medication, 15 (78.9%) had elevated blood pressure (defined as systolic blood pressure > 140 mmHg or diastolic BP > 90 mmHg) at the time of the survey. The rate of uncontrolled hypertension was nearly as high (69.7%) among those with self-reported compliance.
To assess factors that might make hypertensive persons non-complaint with their medication, whether or not they were currently taking their drugs, twenty statements related to reasons for non-compliance were administered to all 52 study participants by trained assistants. Each statement was read and participants were asked to select 'not sure', 'somewhat sure' or 'very sure'. Selection of 'very sure' was graded as being compliant, while the other selections were deemed as an indication of some level of non-compliance.
RESULTS AND DISCUSSION
The top three factors related to compliance were the occurrence of adverse effects, the need to take medication in the absence of symptoms associated with hypertension and convenience of dosing (Table) . The percentage expressing likely non-compliance ranged from 9.6% to 40.4%. These factors are similar to a previous study by Düsing et al (5) with some differences, as this survey identified adverse effects as the top reason.
The fact that so many of this group expressed the likelihood of being non-compliant with therapy if they are not experiencing symptoms of the condition is of concern. It suggests a strong perception that hypertension is curable rather than controllable, thus providing further evidence of the need for strategies aimed at educational support.
Diuretics, such as hydrochlorothiazide, form a main group of antihypertensive drugs; the participants (40.4%) highlighted "urination away from home" as a factor likely to be associated with non-compliance. The Caribbean Health Research Council's guidelines for hypertension management specifically describe hydrochlorothiazide therapy as being significantly successful in the Caribbean population (6) .
However, with resistance to taking this drug being related to its diuretic effect, then it is conceivable that the balance between the need for therapy and likely disruptions in a patient's daily activities will make it difficult to effectively implement such treatment. By placing greater emphasis on patient's perceptions, it will be possible to tailor treatment and deliver an individualized educational message to encourage compliance.
On the matter of convenience of drug therapy, obviously there are more frontiers to explore; the participants suggested that current regimen do not quite fit into their daily routines and thus drugs provided to these patients must also facilitate a more holistic approach to management.
The safety of drugs is a multidimensional term, balanced between efficacy and risk assessment. These terms are not mutually exclusive as both are certainly influenced negatively by non-compliance. Tackling the increasing prevalence of hypertension and high prevalence of uncontrolled hypertension will require a team approach to management. Implementation of strategies to address these identified factors that influence compliance will most likely make living with hypertension less intrusive and thus support a better quality of life. 
